CLINICAL_TRIALS
trial_result
· 2022-02-03
Clinical Trial Update: Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC [Phase 4]
Summary
Phase 4 trial update evaluating bladder capacity as an objective measure for intravesical treatment in newly diagnosed interstitial cystitis/painful bladder syn…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Endeavor Health | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 4 | Status: COMPLETED